Precocious puberty girls bone age index and LH peak - base value of the correlation analysis.doc

 PAGE \* MERGEFORMAT 4 Precocious puberty girls bone age index and LH peak / base value of the correlation analysis [Abstract] Objective: To evaluate the bone age in precocious puberty girls index (BAI) and the luteinizing hormone releasing hormone (LHRH) stimulation test LH peak / baseline availability of relevance. Methods: The clinical diagnosis of 54 cases of precocious puberty girls are treated as LHRH stimulation test, taken piece orthotopic left wrist and use the points system software TW2 bone age determination, was bone age indices, respectively, idiopathic central precocious puberty group and the non-central precocity Group for BAI and LH peak / base value of the relevant test. Results: The central precocious puberty in girls, bone age index and LH peak / base value exists linear correlation, non-central precocious puberty group of girls, BAI and the LH peak / base value of no correlation. Conclusion: BAI for screening LHRH stimulation test of significance. [Keywords:] LH peak bone age-based index of the value of the ratio of LHRH stimulation test Precocious puberty is an abnormal growth performance in recent years, an increasing trend. Girls before the age of 8 is generally believed that there shall be signs of precocious sexual development [1]. The hypothalamus - pituitary - gonadal axis hormone secretion change is able to detect the primary clinical indicator of luteinizing hormone releasing hormone (LHRH) stimulation test is a central precocious puberty (CPP) an important means of diagnosis. We passed on the 54 cases of newly diagnosed women for sexual precocity index analysis of bone age children with LHRH stimulation test, bone age of index screening LHRH provocation test case value. A clinical data 1.1 The clinical data of 54 cases of precocious puberty in this group of girls, aged 4 years and 6 months to 8 years 11 months, unilateral or bilateral breast development as the first symptom, to exclude a result of oral intake of estrogen-con